Clinical Trials Browser

Recruiting × Endometrial Neoplasms × durvalumab × Clear all

NCT03682289 2026-04-15

Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors

Phase 2 Recruiting

GastrointestinalGenitourinaryGynecologic

Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Neoplasm Metastasis, Pancreatic Neoplasms, Endometrial Neoplasms

NCT05255653 2024-11-29

RAINBO

Phase 2/3 Recruiting

Endometrial Neoplasms

NCT06680739 2024-11-08

SERPENTINE

Phase 2 Recruiting

GastrointestinalGynecologic

Colorectal Neoplasms, Endometrial Neoplasms